Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-10-13
1997-05-20
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530300, 530303, 536 2351, 435 691, 435 694, 424 145, 424 165, 424 169, A01K 3800, C07H 2104, C12P 2106, A61K 3800, A61K 5100
Patent
active
056312253
ABSTRACT:
A pharmaceutical formulation comprising a growth hormone and isoleucine as additive or buffering substance shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved formulation at ambient temperature.
REFERENCES:
patent: 4056520 (1977-11-01), Sonenberg et al.
patent: 4563352 (1986-01-01), Rivier et al.
patent: 4917685 (1990-04-01), Viswanathan
patent: 5137872 (1992-08-01), Seely et al.
Rabkin et al, "Amer. Jour. Physiol", vol. 242(6), F745-749, 1982.
Wang et al., J. Parenteral Sci. & Tech., Vo. 42, pp. s3-s26 (1988).
Manning et al., Pharma. Research, vol. 6. No. 11, pp. 903-918 (1989).
Becker et al., Biotech. and Applied Biochem., vol. 9, 478-487 (1987).
Johnson et al., J. Biol Chem., vol. 264, No. 24, pp. 14262-14271 (1989).
Becker et al., Biotech. and Applied Biochem., vol. 10, 326-337 (1988).
Houghten et al., Ach. Biochem. & Biophy., vol. 178, pp. 350-355 (1977).
Teh et al., J. Biological Chem., vol. 262, No. 14, pp. 6472-6477 (1987).
Riggin et al., Analytical Biochem., vol. 167, pp. 199-209 (1987).
Gellerfors, Acta Paediatr Scand [Suppl], vol. 370, pp. 93-100 (1990).
Kaufman, Pharmaceutical Research, vol. 7, No. 3, pp. 289-293 (1990).
Dialog accession No. 007545021, WPI accession No. 88-178953/26.
Agris, Esq. Cheryl H.
Kight John
Leary Louise
Novo Nordisk A S
Zelson Esq. Steve T.
LandOfFree
Pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1723898